Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$2.8B
527M shares
52-week range
$1.58 – $5.59
93% from low
Sector
HOSPITAL & MEDICAL SERVICE PLANS
Exchange
NASDAQ
CS
Borrow rate
0.27%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $281.0M | $462.3M | $672.9M | $1.47B | $1.10B | $1.26B | $1.37B | $1.92B |
| Cost of revenue | $0 | $449.7M | $590.1M | $1.55B | $993.1M | $1.00B | $1.01B | $1.57B |
| Gross profit | $281.0M | $12.6M | $82.8M | −$79.2M | $103.5M | $256.0M | $364.8M | $355.9M |
| Gross margin | 100.0% | 2.7% | 12.3% | -5.4% | 9.4% | 20.3% | 26.6% | 18.5% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$185.8M | −$183.2M | −$92.7M | −$637.0M | −$286.7M | −$205.3M | −$45.7M | −$85.5M |
| EBITDA | −$16.1M | −$324.1M | −$78.7M | −$569.6M | −$252.0M | −$207.6M | −$44.9M | −$83.9M |
| Net income | −$201.9M | −$363.7M | −$136.4M | −$587.8M | −$339.6M | −$213.4M | −$43.0M | −$85.5M |
| Net margin | -71.9% | -78.7% | -20.3% | -39.9% | -31.0% | -16.9% | -3.1% | -4.4% |
| EPS (diluted) | -4.81 | -0.90 | -0.23 | -1.25 | -0.71 | -0.45 | -0.09 | -0.17 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $2.9B | $0.04 | $0.04–$0.04 | 1 |
| 2027 | $3.3B | $0.05 | $0.05–$0.05 | 1 |
| 2028 | $3.7B | $0.13 | $0.08–$0.17 | 2 |
| 2029 | $4.3B | $0.21 | $0.21–$0.21 | 1 |
Forward consensus · source: Financial Modeling Prep
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
www.cloverhealth.comNo one on the platform currently holds CLOV.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 3,401,541 | $6.0M |
No one on the platform has traded CLOV yet.
| $2.7B |
| — |
| LFSTLifeStance Health Group, Inc. | $10.28 | +4.05% | $4.0B | — |
| NHCNational HealthCare Corporation | $206.54 | +2.49% | $3.2B | — |
Source: Financial Modeling Prep · peers by sector/industry
$CLOV Remember when Berkshire Hathaway, JP Morgan and Amazon tried to disrupt healthcare? If not Google Haven Health. CLOV is more impressive than you think.
View on StockTwits ↗$CLOV give us a $5B market cap Mr Andrew. I believe your incentivized to do so :-)
View on StockTwits ↗$CLOV what’s the gaiiiiest thing you’ve ever done?
View on StockTwits ↗$CLOV July historically is a monster rally month … I am greedy I want 20
View on StockTwits ↗$CLOV $BB is going fucking crazy. Their share prices had been highly correlated for a long time, so why are they suddenly diverging today?
View on StockTwits ↗@Eartth @Sammmy2605 Bankruptcy would be filed to get relief of debt and $CLOV has no debt. So…
View on StockTwits ↗$CLOV now this should be one hell of a conversation
View on StockTwits ↗$CLOV Big money is rotating into healthcare sector out of overvalued tech, get ready for healthcare to be sexy again.
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
Trading at 1.8× sales vs its 0.9× historical median P/S.
Fair value ≈ $2.59 · price $5.31 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.